| Ryan Peter Carfi, DO | |
|
77 Nealy Ave, Hampton, VA 23665-2040 | |
| (757) 764-2523 | |
| Not Available |
| Full Name | Ryan Peter Carfi |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 77 Nealy Ave, Hampton, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063047660 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 0102207055 (Virginia) | Secondary |
| 207R00000X | Internal Medicine | 0102207055 (Virginia) | Primary |
| Entity Name | Riverside Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194929026 PECOS PAC ID: 5092608448 Enrollment ID: O20040207000400 |
News Archive
Scientists at Jefferson Medical College are using tobacco plants to produce monoclonal antibodies – tiny guided protein missiles – that can target and hunt down cancer cells. The plants promise to provide a cheaper, faster method of producing anticancer antibodies, raising hopes that the technology can one day be used in humans.
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
Those governors who earlier embraced ObamaCare's Medicaid expansion-;here's looking at you, Jan Brewer-;might be feeling a little cheated. If only they had held out a bit longer, they might have been able to obtain something from the Obama administration in return, as Florida's Rick Scott purports to have done.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 9 to 5 that the available data do not adequately demonstrate that the potential benefits of lorcaserin outweigh the potential risks, when used long-term in a population of overweight and obese individuals to allow marketing approval.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Peter Carfi, DO 77 Nealy Ave, Hampton, VA 23665-2040 Ph: (757) 764-2523 | Ryan Peter Carfi, DO 77 Nealy Ave, Hampton, VA 23665-2040 Ph: (757) 764-2523 |
News Archive
Scientists at Jefferson Medical College are using tobacco plants to produce monoclonal antibodies – tiny guided protein missiles – that can target and hunt down cancer cells. The plants promise to provide a cheaper, faster method of producing anticancer antibodies, raising hopes that the technology can one day be used in humans.
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
Those governors who earlier embraced ObamaCare's Medicaid expansion-;here's looking at you, Jan Brewer-;might be feeling a little cheated. If only they had held out a bit longer, they might have been able to obtain something from the Obama administration in return, as Florida's Rick Scott purports to have done.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 9 to 5 that the available data do not adequately demonstrate that the potential benefits of lorcaserin outweigh the potential risks, when used long-term in a population of overweight and obese individuals to allow marketing approval.
› Verified 3 days ago
Dr. Sridhar Madhunapantula, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 100 Emancipation Dr, Hampton, VA 23667 Phone: 757-722-9961 | |
Hayden Allen Ross-clunis Iii, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 100 Emancipation Dr, Hampton, VA 23667 Phone: 757-722-9961 Fax: 757-728-3126 | |
Irene Paula San Roman, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 100 Emancipation Dr, Hampton, VA 23667 Phone: 757-722-9961 | |
Dr. Naga S Chigurupati, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 2207 Executive Dr Ste B, Hampton, VA 23666 Phone: 757-224-8919 | |
Myung Woong Kim, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 501 Medical Dr, Hampton, VA 23666 Phone: 757-826-7785 Fax: 757-826-9028 | |
Stephen E Lapinel, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4000 Coliseum Dr, Suite 350, Hampton, VA 23666 Phone: 757-827-2127 Fax: 757-827-2255 | |
Dr. William Edward Brown Iii, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 Manhattan Sq Ste 100, Hampton, VA 23666 Phone: 757-826-2102 Fax: 757-825-9482 |